Skip to content
lifestyle.womensconference.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cantargia
Invitation to the Presentation of Cantargia’s Interim Report for Q1 2026
May 22, 2026
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
May 21, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
May 20, 2026
Cantargia Publishes Annual Report 2025
May 19, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
May 19, 2026
New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference
March 18, 2026
Cantargia to Participate at Van Lanschot Kempen’s Life Sciences Conference
March 5, 2026
Invitation to the Presentation of Cantargia’s Annual Results for 2025
February 10, 2026
←
Previous Page
1
2